Healthera Secures £2M Funding to Expand Digital Pharmacy Platform and Future-Proof UK Pharmacies

April 17, 2025

Healthera Secures £2M Funding to Expand Digital Pharmacy Platform and Future-Proof UK Pharmacies

Healthera, a digital health platform based in Cambridge, continues to make significant strides in the pharmacy and healthcare technology space. Founded in 2015 by Cambridge University graduates Quintus Liu, Martin Hao, and Jin Da, Healthera has developed a platform that allows users to manage prescriptions and book pharmacy services efficiently. The company also empowers pharmacies to create their own branded versions of the app, fostering stronger patient engagement and customer loyalty.

The growth trajectory for Healthera has been impressive. Since its inception, the company has rapidly expanded its footprint in the UK pharmacy market. Healthera now claims to serve more than 1,700 pharmacies nationwide, a testament to its widespread adoption and the value it brings to both patients and pharmacy partners. This strong market position has attracted the attention of investors and government bodies alike.

In April 2025, Healthera announced an additional £2 million in funding, bringing its Series A round to a total of £5.6 million. The latest investment was led by private investors through the Committed Capital network. Previous funding rounds saw contributions from notable organizations such as Serafund, Cambridge Enterprise, Accelerated Digital Ventures (Legal and General), NHS England, and Innovate UK. This diverse backing highlights the confidence in Healthera’s vision and potential.

Healthera’s mission extends beyond simply digitizing pharmacy services. The company is focused on future-proofing community pharmacies across the UK. This mission received a boost with funding from Innovate UK, which supports the ongoing development of Healthera’s industry-leading platforms for both pharmacies and patients The company expressed excitement about this support, stating, “This helps support us in our mission to future-proof pharmacies across the UK”. The commitment to innovation and growth is clear, with 2023 marked as the fastest growth year yet for Healthera.

The platform’s features are designed to streamline the pharmacy experience for both users and providers. Patients benefit from convenient prescription management and easy access to pharmacy services, while pharmacies can leverage the technology to build stronger relationships with their customers. By offering customizable, branded apps, Healthera enables pharmacies to differentiate themselves in a competitive market and enhance patient loyalty.

Looking ahead, Healthera plans to use its new funding to accelerate growth further, with a particular focus on expanding into North America. This international ambition signals the company’s confidence in its scalable technology and the universal need for digital health solutions in pharmacy care. The expansion strategy aims to replicate the success seen in the UK and bring Healthera’s innovative approach to a broader audience.

Healthera’s journey is marked by strong partnerships with both investors and community pharmacies. The company has publicly thanked its backers and pharmacy partners for their continued support, emphasizing the collaborative nature of its growth. As Healthera continues to innovate and expand, it remains committed to its core mission of empowering pharmacies and improving patient outcomes through technology.

With a robust platform, a growing network of pharmacy partners, and strong investor confidence, Healthera is well-positioned to shape the future of digital pharmacy services. The company’s ongoing development and expansion efforts are set to further solidify its role as a leader in the digital health sector. As the healthcare landscape evolves, Healthera’s focus on technology-driven solutions promises to deliver lasting benefits for both pharmacies and patients alike.